Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myles Wolf

Showing results (111-120 of 308) with videos related to

Pageof 31
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 4, 2022
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort StudyGaurang Garg, Yacob G Tedla, Anika S Ghosh, et al.
American Journal of Nephrology|March 2, 2019
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO StudyAnna Jovanovich, Zhiying You, Tamara Isakova, et al.
Scientific Reports|June 22, 2019
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO studyKeitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, et al.
American Journal of Obstetrics and Gynecology|July 10, 2007
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restrictionIlana Chafetz, Ido Kuhnreich, Marei Sammar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2012
FGF-23 levels in patients with AKI and risk of adverse outcomesDavid E Leaf, Myles Wolf, Sushrut S Waikar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 16, 2010
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney diseaseTamara Isakova, Orlando M Gutiérrez, Kelsey Smith, et al.
Journal of the American Society of Nephrology : JASN|May 27, 2005
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney diseaseOrlando Gutierrez, Tamara Isakova, Eugene Rhee, et al.
Kidney International|February 5, 2010
Vitamin D deficiency and anemia in early chronic kidney diseaseNeha M Patel, Orlando M Gutiérrez, Dennis L Andress, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemiaGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2012
(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteersOrlando M Gutiérrez, Kelsey T Smith, Allison Barchi-Chung, et al.
Pageof 31

Showing results (111-120 of 308) with videos related to

Sort By:
Pageof 31
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 4, 2022
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort StudyGaurang Garg, Yacob G Tedla, Anika S Ghosh, et al.
American Journal of Nephrology|March 2, 2019
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO StudyAnna Jovanovich, Zhiying You, Tamara Isakova, et al.
Scientific Reports|June 22, 2019
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO studyKeitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, et al.
American Journal of Obstetrics and Gynecology|July 10, 2007
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restrictionIlana Chafetz, Ido Kuhnreich, Marei Sammar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2012
FGF-23 levels in patients with AKI and risk of adverse outcomesDavid E Leaf, Myles Wolf, Sushrut S Waikar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 16, 2010
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney diseaseTamara Isakova, Orlando M Gutiérrez, Kelsey Smith, et al.
Journal of the American Society of Nephrology : JASN|May 27, 2005
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney diseaseOrlando Gutierrez, Tamara Isakova, Eugene Rhee, et al.
Kidney International|February 5, 2010
Vitamin D deficiency and anemia in early chronic kidney diseaseNeha M Patel, Orlando M Gutiérrez, Dennis L Andress, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemiaGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2012
(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteersOrlando M Gutiérrez, Kelsey T Smith, Allison Barchi-Chung, et al.
Pageof 31